Familial Mediterranean Fever (FMF) is an autosomal recessive autoinflammatory disorder caused by mutations in the MEFV gene. It is most common among populations from the Eastern Mediterranean region, including Turks, Armenians, Arabs, and Sephardic Jews. One of the most serious complications of FMF is AA amyloidosis, which develops as a result of chronic inflammation and the deposition of serum amyloid A protein. AA amyloidosis frequently affects the kidneys, leading to nephrotic syndrome and chronic kidney disease.
We report a case of a 17-year-old Turkish male presenting with recurrent episodes of fever, joint pain, periodic skin rashes, and intermittent hypertension. Laboratory evaluation revealed nephrotic-range proteinuria, hypoalbuminemia, low serum IgG, and elevated inflammatory markers. Renal biopsy confirmed AA amyloidosis with moderate interstitial lymphocytic infiltration and mild fibrosis. Genetic testing identified a homozygous pathogenic variant in exon 10 of the MEFV gene (p.Met694Val), previously reported and strongly associated with FMF.
This case highlights the rarity of such presentations and emphasizes the importance of early diagnosis of FMF complicated by AA amyloidosis. The patient remains on colchicine therapy with careful monitoring for potential complications; corticosteroids were gradually tapered following confirmation of amyloidosis, with supportive and symptomatic management continued.
AA-Amyloidosis in an Adolescent with Familial Mediterranean Fever: A Case Report
Central Asian Journal of Nephrology, 1(2), 2025, cajn008, https://doi.org/10.63946/cajn/17421
Publication date: Nov 14, 2025
ABSTRACT
KEYWORDS
Familial Mediterranean Fever Secondary amyloidosis (AA) MEFV protein nephrotic syndrome renal biopsy
CITATION (Vancouver)
Rakhimzhanova S, Shaimardanova G, Smagulova A, Nalibek A. AA-Amyloidosis in an Adolescent with Familial Mediterranean Fever: A Case Report. Central Asian Journal of Nephrology. 2025;1(2):cajn008. https://doi.org/10.63946/cajn/17421
APA
Rakhimzhanova, S., Shaimardanova, G., Smagulova, A., & Nalibek, A. (2025). AA-Amyloidosis in an Adolescent with Familial Mediterranean Fever: A Case Report. Central Asian Journal of Nephrology, 1(2), cajn008. https://doi.org/10.63946/cajn/17421
Harvard
Rakhimzhanova, S., Shaimardanova, G., Smagulova, A., and Nalibek, A. (2025). AA-Amyloidosis in an Adolescent with Familial Mediterranean Fever: A Case Report. Central Asian Journal of Nephrology, 1(2), cajn008. https://doi.org/10.63946/cajn/17421
AMA
Rakhimzhanova S, Shaimardanova G, Smagulova A, Nalibek A. AA-Amyloidosis in an Adolescent with Familial Mediterranean Fever: A Case Report. Central Asian Journal of Nephrology. 2025;1(2), cajn008. https://doi.org/10.63946/cajn/17421
Chicago
Rakhimzhanova, Saltanat, Galiya Shaimardanova, Aigerim Smagulova, and Aidana Nalibek. "AA-Amyloidosis in an Adolescent with Familial Mediterranean Fever: A Case Report". Central Asian Journal of Nephrology 2025 1 no. 2 (2025): cajn008. https://doi.org/10.63946/cajn/17421
MLA
Rakhimzhanova, Saltanat et al. "AA-Amyloidosis in an Adolescent with Familial Mediterranean Fever: A Case Report". Central Asian Journal of Nephrology, vol. 1, no. 2, 2025, cajn008. https://doi.org/10.63946/cajn/17421
REFERENCES
- Mirioglu S, Uludag O, Hurdogan O, Kumru G, Berke., et al. AA Amyloidosis: A Contemporary View. Curr Rheumatol Rep. 2024;26:248–259. DOI: 10.1007/s11926-024-01147-8
- Bektas M, Koca N, Oguz E, Sari S, Dagci G., et al. Characteristics and course of patients with AA amyloidosis. Rheumatology (Oxford). 2024;63(2):319–328. DOI: 10.1093/rheumatology/kead465
- Yamada S, Parada X, Pasala S, Anumolu R, Alenizi S. AA amyloidosis unveiling familial Mediterranean fever in an atypical presentation. J Am Soc Nephrol. 2024;35:837–846. DOI: 10.1681/ASN.20241sjr2vxm
- Ozeri DJ, Bar D, Safran BS, Druyan A, Kukuy OL, et al. Renal outcomes and survival in amyloidosis associated with FMF. Semin Arthritis Rheum. 2025;10:1035–1048. DOI: 10.1016/j.semarthrit.2025.152642
- Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, et al. Familial Mediterranean fever: a comprehensive review. Ann Rheum Dis. 2016;75(4):644–51. DOI: 10.1136/annrheumdis-2015-208690
- Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356:2361–2371. DOI: 10.1056/NEJMoa070265
- GeneReviews®. Familial Mediterranean Fever. NCBI Bookshelf. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1226/.
- Yin X, Tian F, Wu B, Xu T. Interventions for reducing inflammation in FMF: systematic review. Cochrane Database Syst Rev. 2022;CD013456. DOI: 10.1002/14651858.CD010893.pub4
- Lancieri M, Bustaffa M, Palmeri S, Prigione I, Penco F, et al. An Update on Familial Mediterranean Fever. Int J Mol Sci. 2023;24(11):9584. DOI: 10.3390/ijms24119584
- Mukhin NA, Kozlovskaya LV, Bogdanova MV, Rameev VV, Moiseev SV, Simonyan AKh. Predictors of AA amyloidosis in familial Mediterranean fever. Rheumatol Int. 2015;17:238. DOI: 10.1007/s00296-014-3205-x
- Hosman IS, Kos I, Lamot L. Serum Amyloid A in Inflammatory Rheumatic Diseases. Front Immunol. 2021;11:631299. DOI: 10.3389/fimmu.2020.631299
- Biederman LE, Dasgupta AD, Dreyfus DE, Nadasdy T, Satoskar AA, Brodsky SV. Kidney Biopsy Corner: Amyloidosis. Glomerular Dis. 2023;3(1):165-177. DOI: 10.1159/000533195
- StatPearls. Familial Mediterranean Fever. 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK570556/.
LICENSE
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.